A family-based approach reveals the function of residues in the nuclear receptor ligand-binding domain.
暂无分享,去创建一个
Emmanuel Bettler | Henk-Jan Joosten | Simon Folkertsma | Florence Horn | Jacob de Vlieg | Laerte Oliveira | G. Vriend | W. Fleuren | J. van Durme | J. de Vlieg | P. V. van Noort | H. Joosten | E. Bettler | Paula van Noort | Joost Van Durme | Wilco Fleuren | Gerrit Vriend | S. Folkertsma | Laerte Oliveira | F. Horn | Joost van Durme
[1] William Bourguet,et al. Crystal structure of the ligand-binding domain of the human nuclear receptor RXR-α , 1995, Nature.
[2] D. Moras,et al. Structural basis for isotype selectivity of the human retinoic acid nuclear receptor. , 2000, Journal of molecular biology.
[3] H. Gronemeyer,et al. Nuclear receptor ligand-binding domains: three-dimensional structures, molecular interactions and pharmacological implications. , 2000, Trends in pharmacological sciences.
[4] W. Kabsch,et al. Structure of the guanine-nucleotide-binding domain of the Ha-ras oncogene product p21 in the triphosphate conformation , 1989, Nature.
[5] Joost J. J. van Durme,et al. NRMD: Nuclear Receptor Mutation Database , 2003, Nucleic Acids Res..
[6] H. Wolfson,et al. Flexible protein alignment and hinge detection , 2002, Proteins.
[7] B. Katzenellenbogen,et al. Allosteric control of ligand selectivity between estrogen receptors alpha and beta: implications for other nuclear receptors. , 2004, Molecular cell.
[8] R. Huber,et al. Structure of the complex formed by bovine trypsin and bovine pancreatic trypsin inhibitor. Crystal structure determination and stereochemistry of the contact region. , 1973, Journal of molecular biology.
[9] Shmuel Pietrokovski,et al. The Blocks database--a system for protein classification , 1996, Nucleic Acids Res..
[10] Fred E. Cohen,et al. Automated extraction of mutation data from the literature: application of MuteXt to G protein-coupled receptors and nuclear hormone receptors , 2004, Bioinform..
[11] Jimin Pei,et al. AL2CO: calculation of positional conservation in a protein sequence alignment , 2001, Bioinform..
[12] L. Mirny,et al. Universally conserved positions in protein folds: reading evolutionary signals about stability, folding kinetics and function. , 1999, Journal of molecular biology.
[13] Gert Vriend,et al. Collecting and harvesting biological data: the GPCRDB and NucleaRDB information systems , 2001, Nucleic Acids Res..
[14] L. Pauling,et al. Evolutionary Divergence and Convergence in Proteins , 1965 .
[15] M. Lambert,et al. Structural basis for autorepression of retinoid X receptor by tetramer formation and the AF-2 helix. , 2000, Genes & development.
[16] S. Jones,et al. Prediction of protein-protein interaction sites using patch analysis. , 1997, Journal of molecular biology.
[17] Rama Ranganathan,et al. Structural Determinants of Allosteric Ligand Activation in RXR Heterodimers , 2004, Cell.
[18] T. N. Bhat,et al. The Protein Data Bank , 2000, Nucleic Acids Res..
[19] T. Willson,et al. Ligand binding and co-activator assembly of the peroxisome proliferator-activated receptor-γ , 1998, Nature.
[20] John A. Katzenellenbogen,et al. Allosteric Control of Ligand Selectivity between Estrogen Receptors α and β - Implications for Other Nuclear Receptors , 2004 .
[21] J. Gustafsson,et al. Comparing nuclear receptors in worms, flies and humans. , 2001, Trends in pharmacological sciences.
[22] T. Gibson,et al. Applying motif and profile searches. , 1996, Methods in enzymology.
[23] M L Lamb,et al. Computational approaches to molecular recognition. , 1997, Current opinion in chemical biology.
[24] D. Moras,et al. Structural and functional evidence for ligand-independent transcriptional activation by the estrogen-related receptor 3. , 2002, Molecular cell.
[25] P. Chambon,et al. Crystal structure of a heterodimeric complex of RAR and RXR ligand-binding domains. , 2000, Molecular cell.
[26] L. Mirny,et al. Evolutionary conservation of the folding nucleus. , 2000, Journal of molecular biology.
[27] D. Mangelsdorf,et al. Unique requirements for retinoid-dependent transcriptional activation by the orphan receptor LXR. , 1997, Genes & development.
[28] A B Jones,et al. Peroxisome proliferator‐activated receptor (PPAR) modulators: Diabetes and beyond * , 2001, Medicinal research reviews.
[29] A. Hopkins,et al. The druggable genome , 2002, Nature Reviews Drug Discovery.
[30] John P. Overington,et al. From comparisons of protein sequences and structures to protein modelling and design. , 1990, Trends in biochemical sciences.
[31] Xiaohong Liu,et al. Structure and function of Nurr1 identifies a class of ligand-independent nuclear receptors , 2003, Nature.
[32] G Vriend,et al. WHAT IF: a molecular modeling and drug design program. , 1990, Journal of molecular graphics.
[33] J. Aubin,et al. Estrogen receptor-related receptor alpha impinges on the estrogen axis in bone: potential function in osteoporosis. , 2002, Endocrinology.
[34] J. Lehmann,et al. Orphan nuclear receptors: shifting endocrinology into reverse. , 1999, Science.
[35] Maria Jesus Martin,et al. The SWISS-PROT protein knowledgebase and its supplement TrEMBL in 2003 , 2003, Nucleic Acids Res..
[36] F. Cohen,et al. An evolutionary trace method defines binding surfaces common to protein families. , 1996, Journal of molecular biology.
[37] T. Willson,et al. Asymmetry in the PPARgamma/RXRalpha crystal structure reveals the molecular basis of heterodimerization among nuclear receptors. , 2000, Molecular cell.
[38] P. Kollman,et al. Biomolecular simulations: recent developments in force fields, simulations of enzyme catalysis, protein-ligand, protein-protein, and protein-nucleic acid noncovalent interactions. , 2001, Annual review of biophysics and biomolecular structure.
[39] Millard H. Lambert,et al. Structural basis for antagonist-mediated recruitment of nuclear co-repressors by PPARα , 2002, Nature.
[40] T. Willson,et al. Peroxisome proliferator-activated receptors: from genes to physiology. , 2001, Recent progress in hormone research.
[41] William Hyde Wollaston,et al. I. The Croonian Lecture , 1810, Philosophical Transactions of the Royal Society of London.
[42] B. Honig,et al. Classical electrostatics in biology and chemistry. , 1995, Science.
[43] R. Evans,et al. The phantom ligand effect: allosteric control of transcription by the retinoid X receptor. , 1997, Genes & development.
[44] David A. Agard,et al. The Structural Basis of Estrogen Receptor/Coactivator Recognition and the Antagonism of This Interaction by Tamoxifen , 1998, Cell.
[45] Millard H. Lambert,et al. Asymmetry in the PPARγ/RXRα Crystal Structure Reveals the Molecular Basis of Heterodimerization among Nuclear Receptors , 2000 .
[46] B. Katzenellenbogen,et al. Nuclear hormone receptors: ligand-activated regulators of transcription and diverse cell responses. , 1996, Chemistry & biology.
[47] A G Murzin,et al. SCOP: a structural classification of proteins database for the investigation of sequences and structures. , 1995, Journal of molecular biology.
[48] R J Fletterick,et al. Structure and specificity of nuclear receptor-coactivator interactions. , 1998, Genes & development.
[49] R. Fletterick,et al. Structural basis for ligand-independent activation of the orphan nuclear receptor LRH-1. , 2003, Molecular cell.
[50] M. Perutz,et al. The Croonian Lecture, 1968 - The haemoglobin molecule , 1969, Proceedings of the Royal Society of London. Series B. Biological Sciences.
[51] I. Kuntz,et al. Using shape complementarity as an initial screen in designing ligands for a receptor binding site of known three-dimensional structure. , 1988, Journal of medicinal chemistry.
[52] William Bourguet,et al. A canonical structure for the ligand-binding domain of nuclear receptors , 1996, Nature Structural Biology.
[53] J M Blaney,et al. A geometric approach to macromolecule-ligand interactions. , 1982, Journal of molecular biology.
[54] D. Moras,et al. LIGAND-BINDING DOMAIN OF THE HUMAN NUCLEAR RECEPTOR RXR-ALPHA , 1996 .
[55] K. Umesono,et al. The nuclear receptor superfamily: The second decade , 1995, Cell.
[56] C. Sander,et al. Detection of common three‐dimensional substructures in proteins , 1991, Proteins.
[57] M J Sternberg,et al. Supersites within superfolds. Binding site similarity in the absence of homology. , 1998, Journal of molecular biology.
[58] Howard M. Einspahr,et al. Crystallographic structures of the ligand-binding domains of the androgen receptor and its T877A mutant complexed with the natural agonist dihydrotestosterone , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[59] Phillip T. Hawkins,et al. Crystal Structure and Functional Analysis of Ras Binding to Its Effector Phosphoinositide 3-Kinase γ , 2000, Cell.
[60] J. Kendrew,et al. Structure of Deoxymyoglobin : A Crystallographic Study , 1966, Nature.
[61] R. Evans,et al. The steroid and thyroid hormone receptor superfamily. , 1988, Science.
[62] J. Lees,et al. Identification of a conserved region required for hormone dependent transcriptional activation by steroid hormone receptors. , 1992, The EMBO journal.
[63] Laerte Oliveira,et al. Sequence analysis reveals how G protein–coupled receptors transduce the signal to the G protein , 2003, Proteins.
[64] G. Whitfield. "A highly conserved region in the hormone-binding domain of the human vitamin D receptor contains residues vital for heterodimerization with retinoid X receptor and for transcriptional activation". , 1995, Molecular endocrinology.
[65] P. Hawkins,et al. Crystal structure and functional analysis of Ras binding to its effector phosphoinositide 3-kinase gamma. , 2000, Cell.
[66] F. Claessens,et al. Interaction of the putative androgen receptor-specific coactivator ARA70/ELE1alpha with multiple steroid receptors and identification of an internally deleted ELE1beta isoform. , 1999, Molecular endocrinology.
[67] J Deisenhofer,et al. Structure of the complex formed by bovine trypsin and bovine pancreatic trypsin inhibitor. II. Crystallographic refinement at 1.9 A resolution. , 1974, Journal of molecular biology.
[68] Laerte Oliveira,et al. Identification of functionally conserved residues with the use of entropy–variability plots , 2003, Proteins.
[69] M. Karplus,et al. Functionality maps of binding sites: A multiple copy simultaneous search method , 1991, Proteins.
[70] B. Erman,et al. Information‐theoretical entropy as a measure of sequence variability , 1991, Proteins.
[71] W. Kabsch,et al. Refined crystal structure of the triphosphate conformation of H‐ras p21 at 1.35 A resolution: implications for the mechanism of GTP hydrolysis. , 1990, The EMBO journal.
[72] M. Perutz. Stereochemistry of cooperative effects in haemoglobin. , 1970, Nature.
[73] D. Eisenberg,et al. Three-dimensional cluster analysis identifies interfaces and functional residue clusters in proteins. , 2001, Journal of molecular biology.
[74] D. Tindall,et al. The role of the androgen receptor in prostate cancer. , 2002, Critical reviews in eukaryotic gene expression.
[75] L. Moore,et al. The Human Nuclear Xenobiotic Receptor PXR: Structural Determinants of Directed Promiscuity , 2001, Science.
[76] T. Blundell,et al. Evolutionary trace analysis of TGF-beta and related growth factors: implications for site-directed mutagenesis. , 2000, Protein engineering.
[77] C. Sander,et al. A method to predict functional residues in proteins , 1995, Nature Structural Biology.
[78] Dino Moras,et al. Structural adaptability in the ligand-binding pocket of the ecdysone hormone receptor , 2003, Nature.
[79] Lan Huang,et al. Structural basis for the interaction of Ras with RaIGDS , 1998, Nature Structural Biology.
[80] Zbigniew Dauter,et al. Molecular basis of agonism and antagonism in the oestrogen receptor , 1997, Nature.
[81] W. Hendrickson,et al. Structural transitions upon ligand binding in a cooperative dimeric hemoglobin. , 1990, Science.
[82] V. Bryson,et al. Evolving Genes and Proteins. , 1965, Science.
[83] K. Kaibuchi,et al. Small GTP-binding proteins. , 1992, International review of cytology.
[84] K. Umesono,et al. A Unified Nomenclature System for the Nuclear Receptor Superfamily , 1999, Cell.